Menu

April 28, 2016, 12:00 pm – 1:30 pm CT / 1:00 pm – 2:30 pm ET

The Opioid Patient Safety Crisis: Actions and Reactions

Session Overview

Opioid related adverse events have become a critical patient safety issue as evidenced by actions taken last month by the FDA (see link: http://www.fda.gov/NewsEvents/Newsroom/FactSheets/ucm484714.htm) and CDC (see link: http://www.cdc.gov/drugoverdose/prescribing/guideline.html).

We are proud to have Dr. Gladstone McDowell as our speaker; Dr. McDowell speaks extensively on the topic of pain management and the use and misuse of opioid medications. He will discuss the latest patient safety developments and current strategies to optimize opioid use in the context of the “5 Rights of Pain Care®.”  After his presentation, Dr. McDowell will be joined by members of a reactor panel who will discuss the key takeaways with our experts, and respond to questions from our webinar participants.

We offer these online webinars at no cost to our participants.

……………………………………………………………………………………………………..

Webinar Video, and Downloads


Webinar Video:

National Survey Results:

Click here to download the National Survey Results.

Speaker Slide Set:

Click here to download the combined speakers’ slide set in PDF format – one (1) slide per page. 
Click here to download the combined speakers’ slide set in PDF format – four (4) slides per page. 

To view the file, click the desired link (please note: the files may take several minutes to download). To save to your hard drive, right click on the link and choose “Save Target As.” (In some browsers it might say “Save Link As.”)

……………………………………………………………………………………………………..

Registration Information and CE Credit Information

Register:  The webinar has previously taken place. See webinar video above.

 Webinar date:  April 28, 2016

      Time:

  • 01:00 PM to 2:30 PM Eastern Daylight Time
  • 12:00 PM to 1:30 PM  Central Daylight Time
  • 11:00 AM to 12:30 PM  Mountain Daylight Time
  • 10:00 AM to a1:30 AM  Pacific Daylight Time

We are accepting questions now that relate to the session topics. Please e-mail any questions related to the specific session to webinars@safetyleaders.org with the session title in the e-mail message header.

  • Questions about the Webinar series?
    E-mail webinars@safetyleaders.org or call 512-473-2370 between 9:00 a.m. and 4:30 p.m. CT.
  • Need technical assistance with registration? Call 512-457-7605 between 9:00 a.m. and 4:30 p.m. CT.


Learning Objectives:

  • Awareness: Participants will understand and be able to communicate the latest information regarding frequency, severity, and preventability of errors, harm, and harm due to errors in OPIOID use.
  • Accountability: Participants will understand WHO is accountable for new behaviors to protect patients and caregivers from errors and harm with OPIOIDS.
  • Ability: Participants will learn the principles of importance in education and how to enable key actors to reduce errors and harm with OPIOIDS.
  • Action: Participants will learn what direct line-of-sight actions must be taken to prevent and reduce the harm of OPIOID-related ADEs.

CE Participation Documentation

Texas Medical Institute of Technology, approved by the California Board of Registered Nursing, Provider Number 15996, will be issuing 1.5 contact hours for this webinar. TMIT is only providing nursing credit at this time.

To request a Participation Document, please click here.

……………………………………………………………………………………………………..

Session Speakers and Panelists

Gladstone C. McDowell, II, MD
Gladstone C. McDowell, II, MD The Opioid Patient Safety Crisis
Bio
Dan Ford, LFACHE
Dan Ford, LFACHEDiscussion and Reaction to Presentations AND the Voice of Patient and Family
Bio
Becky Martins
Becky MartinsDiscussion and Reaction to Presentations
Bio
Arlene Salamendra
Arlene Salamendra Discussion and Reaction to Presentation
Bio
Jennifer Dingman
Jennifer DingmanDiscussion and Reaction to Presentation
Bio
C. R. Denham, II, MD
C. R. Denham, II, MDIn the News and Recent Polling
Bio

Related Resources

  1. Editorial Board. Painkiller abuses and ignorance. The New York Times March 2, 2015:A18. Available at http://www.nytimes.com/2015/03/02/opinion/painkiller-abuses-and-ignorance.html.   
  2. Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief. 2015 Feb;(189):1-8. Available at http://www.cdc.gov/nchs/data/databriefs/db189.pdf.   
  3. Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med2011 Nov 24;365(21):2002-12. Available at http://www.nejm.org/doi/pdf/10.1056/NEJMsa1103053.   
  4. Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA 2015 Mar 3;313(9):891-2. Available at http://jama.jamanetwork.com/article.aspx?articleid=2107540.   
  5. Islam MM, McRae IS. An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol 2014 Aug 16;15:46. Available at http://www.biomedcentral.com/content/pdf/2050-6511-15-46.pdf.   
  6. McPherson ML. Strategies for the management of opioid-induced adverse effects. University of Tennessee Advanced Studies in Pharmacy 2008 Jun;5(2):52-7. Available at http://www.utasip.com/files/articlefiles/pdf/3rd%20article.pdf.   
  7. [No authors listed.] Safe use of opioids in hospitals. Sentinel Event Alert Issue 49. Oakbrook Terrace (IL): The Joint Commission; 2012 Aug 8. Available at http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.pdf.   
  8. Warner M, Hedegaard H, Chen L-H. Trends in drug-poisoning deaths involving opioid analgesics and heroin: United States, 1999-2012. NCHS Health E-Stat. Atlanta (GA): Centers for Disease Control and Prevention; 2014 Dec 2. Available athttp://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning_deaths_1999-2012.pdf.   
  9. Yokell MA, Delgado MK, Zaller ND, et al. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Intern Med 2014 Dec;174(12):2034-7. Available at http://archinte.jamanetwork.com/article.aspx?articleid=1918924.   
  10. IOM (Institute of Medicine). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Report Brief. Washington, DC: The National Academies Press; 2011 Jun. Available athttp://www.iom.edu/~/media/Files/Report%20Files/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research/Pain%20Research%202011%20Report%20Brief.pdf.   
  11. IOM (Institute of Medicine). Committee on Advancing Pain Research, Care, and Education; Board on Health Sciences Policy. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press; 2011 Jun. Available at http://www.nap.edu/catalog.php?record_id=13172.   
  12. U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington, DC: U.S. Department of Health and Human Services; 2014. Available at http://www.health.gov/hai/pdfs/ADE-Action-Plan-508c.pdf.   
  13. AHRQ. Efforts to improve patient safety result in 1.3 million fewer patient harms: Interim update on 2013 annual hospital-acquired condition rate and estimates of cost savings and deaths averted from 2010 to 2013. Rockville (MD): Agency for Healthcare Research and Quality; 2014 Dec. Available at http://www.ahrq.gov/professionals/quality-patient-safety/pfp/interimhacrate2013.html.   
  14. Denham CR. Is your hospital as safe as your bank? – Time to ask your board. J Patient Saf 2009 Jun;5(2):122-6. Available at http://journals.lww.com/journalpatientsafety/.   
  15. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med 2015 Feb 17;162(4):276-86. Available at http://annals.org/data/Journals/AIM/932765/0000605-201502170-00006.pdf.   
  16. National Quality Forum. Safe Practice 1: Culture of Safety Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at:
    http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  17. National Quality Forum. Safe Practice 2: Culture Measurement, Feedback, and Intervention. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  18. National Quality Forum. Safe Practice 3: Teamwork Training and Skill Building. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  19. National Quality Forum. Safe Practice 4: Risks and Hazards. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  20. National Quality Forum. Chapter 9: Opportunities for Patient and Family Involvement. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at
    http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.